Liquid-based e-cigarettes emit 12 times more ultrafine dust than regular cigarettes, according to a recent study by the Korea Disease Control and Prevention Agency.
By photographing smoke and aerosols emitted from cigarettes to analyze their chemical composition, the results showed that liquid-based e-cigarettes emitted 172,845 micrograms (㎍) of ultrafine dust per 0.2 grams of liquid, 12 times more than what was emitted by non-electronic cigarettes.
Meanwhile, heated e-cigarettes emitted 3,100 ㎍ of ultrafine dust per cigarette, lower than emissions from non-electronic cigarettes.
Over a three-minute period, the ultrafine dust emitted by liquid-based e-cigarettes spread as far as 10 meters, heated e-cigarettes to between 6 and 7 meters and non-electronic cigarettes to 3 meters.
The study also revealed that black carbon, a chemical related to the automobile emissions stains, is released by all three types of cigarettes.
The highest black carbon levels were from non-electronic cigarettes, which were also present in liquid-based e-cigarettes (98.8 ㎍ per piece) and heated e-cigarettes (11.41 ㎍ per piece).
h invites itself on the King Platinum.


Novo Nordisk Launches Once-Daily Wegovy Pill in U.S. at Competitive Pricing
Bank of Japan Signals Readiness for Near-Term Rate Hike as Inflation Nears Target
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Fed Governor Lisa Cook Warns Inflation Risks Remain as Rates Stay Steady
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
GLP-1 Weight Loss Pills Set to Reshape Food and Fast-Food Industry in 2025
Trump’s Inflation Claims Clash With Voters’ Cost-of-Living Reality
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
Sanofi Gains China Approval for Myqorzo and Redemplo, Strengthening Rare Disease Portfolio
Federal Appeals Court Blocks Trump-Era Hospital Drug Rebate Plan
Merck Raises Growth Outlook, Targets $70 Billion Revenue From New Drugs by Mid-2030s
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies 



